LiMLiX.Letter: CXCL1 index may act as a potential biomarker of plaque instability in patients with carotid stenosis. Angiology. 2025;76(10):1033-4.
2.
KazmierskiPSzpakowskiPGlabinskiA. CXCL1 as a potential biomarker of plaque instability in carotid stenosis. Preliminary report. Angiology. 2025;76(10):955-62.
3.
KaźmierskiPKacperskaMFiglusMTomasikB.The formation of atherosclerotic plaque, its destabilization, and diagnostics. Aktualn Neurol. 2014;14:43-53.
4.
PackardRRLibbyP.Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clin Chem. 2008;54:24-38.
5.
van der VorstEDöringYWeberC. Chemokines and their receptors in Atherosclerosis. J Mol Med. 2015;93:963-71.
6.
ZerneckeAWeberC.Chemokines in atherosclerosis: proceedings resumed. Arterioscler Thromb Vasc Biol. 2014:34:742-50.
7.
WangYLuoWStrickerRReiserG.Protease-activated receptor-1 protects rat astrocytes from apoptotic cell death via JNK-mediated release of the chemokine GRO/CINC-1. J Neurochem. 2006;98:1046-60.
8.
CharoIFRansohoffRM.The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med. 2006;354:610-21.
9.
WeberCSchoberAZerneckeA.Chemokines: key regulators of mononuclear cell recruitment in atherosclerotic vascular disease. Arterioscler Thromb Vasc Biol. 2004;24:1997-2008.
BrelandUMHalvorsenBHolJ, et al. A potential role of the CXC chemokine GRO α in atherosclerosis and plaque destabilization. downregulatory effects of statins. Arterioscler Thromb Vasc Biol. 2008;28:1005-11.
